3D Systems (DDD) Q4 2025: Aerospace and Defense Grows 16%, Anchoring Strategic Turnaround
3D Systems capped 2025 with a sequential revenue surge, led by aerospace and defense strength and tight cost discipline. Focused execution on high-value end markets and portfolio refresh is yielding early traction, even as core industrial demand remains uneven. Management’s 2026 playbook prioritizes sustainable, high-margin growth segments while further optimizing expenses and capital structure.
Summary
- Aerospace and Defense Outpaces: High-value metal printing and casting drove outperformance in industrial solutions.
- Cost Base Reset: Operating expense reductions exceeded targets, unlocking margin leverage for 2026.
- Growth Segments Prioritized: Dental and personalized health services set up as next major revenue streams.
Performance Analysis
3D Systems delivered a 16% sequential revenue jump in Q4, outpacing guidance and reflecting both seasonal strength and accelerating traction in its three priority growth markets: aerospace and defense, personalized health services (PHS), and dental. The company’s industrial solutions segment, now increasingly anchored by aerospace and defense, saw robust printer and parts demand, while the healthcare solutions business was buoyed by dental materials and PHS momentum.
Despite this strong finish, full-year revenue was down 7% year-over-year when excluding divested assets, underscoring the macro headwinds and uneven recovery in core industrial demand. Gross margin for the year slipped modestly, pressured by lower volumes and a heavier printer mix, but was partially offset by the company’s decisive cost reduction actions. Operating expenses fell 19% for the year, surpassing the $50 million savings target and positioning the business for improved EBITDA performance as volumes recover.
- Aerospace and Defense Expansion: Segment grew 16% YoY, becoming the largest industrial market and poised for 20%+ growth in 2026.
- Dental Inflection: NextDent jet denture platform launched, targeting a global market of 180 million denture wearers.
- PHS Delivers Stability: Personalized health services saw double-digit growth and now leads healthcare revenue mix.
Management’s commentary and Q&A confirmed that the company’s revenue base is shifting toward more defensible, high-value applications, with recurring materials and services revenue expected to rise as installed base refresh and product launches gain momentum.
Executive Commentary
"Despite global economic and geopolitical challenges... we've reduced overall operating costs, while selectively doubling down on those industries where additive manufacturing is poised to reshape the market and where we have a unique competitive advantage."
Dr. Jeffrey Graves, President and CEO
"To date, our cost reduction and efficiency programs have delivered approximately $55 million in annualized savings completed in 2025, exceeding our target of $50 million."
Phyllis Nordstrom, Interim CFO
Strategic Positioning
1. Aerospace and Defense: High-Value Metal Printing Takes Center Stage
3D Systems’ aerospace and defense business is now the largest and fastest-growing industrial segment, with 16% growth in 2025 and a 20%+ growth target for 2026. The company’s focus is on high-complexity, high-performance applications—satellites, naval systems, and propulsion components—where direct metal printing and photopolymer casting deliver unique customer value. Recent capacity expansions in Littleton, Colorado, and a proactive response to regulatory tailwinds (NDAA provisions favoring domestic supply) further cement this segment’s trajectory.
2. Personalized Health Services: Recurring Revenue Engine
PHS achieved double-digit growth and is now the largest healthcare segment, driven by innovation in cranial maxillofacial solutions and custom implants. The business model leverages regulatory-cleared, patient-specific devices and deep integration with surgeons, fueling both procedure volume and recurring material sales. The company’s embedded teams at medical research hospitals and new FDA clearances broaden the addressable market for 2026.
3. Dental: Platform Launch Unlocks Global Scale Opportunity
The NextDent jet denture platform, a multi-material, monolithic denture solution, launched in Q4 and is positioned to disrupt a global market of 180 million denture wearers. Digital workflows and rapid production (one-day turnaround) offer a compelling ROI for dental labs, with recurring material revenue potential exceeding $400 million globally. Early adoption and regulatory clearances in the US, New Zealand, and Latin America lay the groundwork for European and Asian expansion in 2026–2027.
4. Cost Structure Optimization: Margin Leverage Ahead
Cost reduction initiatives delivered $55 million in annualized savings, exceeding targets and enabling continued investment in priority growth areas. Operating expense discipline, facility footprint rationalization, and focused R&D allocation have reset the cost base, supporting improved EBITDA even as revenue recovers gradually.
5. Portfolio Breadth and R&D Cycle Management
3D Systems maintains the industry’s broadest technology portfolio, spanning metals and polymers, which provides customer flexibility but requires careful R&D prioritization. Following a heavy refresh cycle, R&D intensity will moderate in 2026, with spend shifting toward incremental platform upgrades and application-specific development in priority markets.
Key Considerations
This quarter marks a strategic inflection as 3D Systems pivots from broad-based industrial exposure to focused, high-value verticals. The company is leveraging its technology breadth and installed base to drive recurring revenue, while cost discipline provides margin resilience.
Key Considerations:
- Industrial Mix Shift: Aerospace and defense now leads industrial revenue, reducing exposure to volatile, low-margin segments.
- Healthcare Stability: PHS and dental provide recurring revenue and regulatory barriers, supporting predictability.
- Cost Reduction Sustainability: Ongoing efficiency programs are critical to margin recovery amid uneven top-line growth.
- Capital Structure Reset: Debt maturities pushed to 2030, with a cash balance of $97 million, providing financial flexibility for targeted investment.
Risks
Macro uncertainty and CapEx restraint among industrial customers remain headwinds, particularly in non-priority end markets. Product mix volatility (printer launches vs. materials pull-through) may pressure gross margins in the near term. Execution risk exists in scaling new dental and PHS platforms globally, and regulatory or competitive shifts could impact adoption curves. The company’s guidance conservatism reflects these uncertainties, with only Q1 outlook provided.
Forward Outlook
For Q1 2026, 3D Systems guided to:
- Revenue of $91 million to $94 million
- Adjusted EBITDA loss of $5 million to $3 million
For full-year 2026, management withheld formal guidance, citing geopolitical uncertainty and macro conditions. Commentary emphasized:
- Continued cost control and margin focus
- Growth in aerospace and defense, PHS, and dental as primary revenue drivers
Takeaways
- Strategic Realignment: The business is now structurally oriented toward high-growth, high-margin verticals, with aerospace and defense as the anchor.
- Margin Rebuild Underway: Cost discipline and portfolio focus are restoring margin leverage, but full recovery hinges on sustained top-line growth and recurring revenue ramp.
- Execution Watchpoint: Investors should monitor adoption rates for new dental and PHS platforms, and the pace at which recurring material and service revenue scales relative to hardware sales.
Conclusion
3D Systems exits 2025 with clear momentum in its targeted growth markets, a leaner cost base, and a capital structure designed for flexibility. The strategic pivot toward high-value, application-driven verticals is underway, but sustained revenue growth and gross margin improvement will be critical watchpoints in 2026.
Industry Read-Through
The rapid growth of additive manufacturing in aerospace, defense, and healthcare signals a maturing industry shift from prototyping to production-scale, mission-critical applications. Regulatory tailwinds and demand for supply chain resilience are accelerating adoption. Peers exposed to low-value, commoditized industrial segments face intensifying margin pressure, while those with advanced materials, regulatory expertise, and integration capabilities are best positioned for durable growth. The dental platform’s digital disruption offers a template for other medtech and industrial players seeking to transition from hardware sales to recurring consumables and services.